G

Gushengtang Holdings Ltd
HKEX:2273

Watchlist Manager
Gushengtang Holdings Ltd
HKEX:2273
Watchlist
Price: 29.7 HKD 0.27% Market Closed
Market Cap: HK$6.8B

Gushengtang Holdings Ltd
Net Issuance of Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Gushengtang Holdings Ltd
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
G
Gushengtang Holdings Ltd
HKEX:2273
Net Issuance of Debt
-¥14.3m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Net Issuance of Debt
¥120.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Net Issuance of Debt
¥111m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Net Issuance of Debt
-¥41.3m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
6%
Dian Diagnostics Group Co Ltd
SZSE:300244
Net Issuance of Debt
-¥944.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Net Issuance of Debt
¥395.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
3%
No Stocks Found

Gushengtang Holdings Ltd
Glance View

Market Cap
6.8B HKD
Industry
Health Care

Gushengtang Holdings Ltd. has woven itself into the fabric of China's healthcare system by focusing on traditional Chinese medicine (TCM), an industry deeply embedded in the nation's culture and ethos. The company operates a network of clinics that provide an array of services, from herbal medicine consultations to acupuncture treatments, leveraging China's growing demand for holistic healthcare solutions. By embracing both traditional practices and modern healthcare technologies, Gushengtang has positioned itself as a key player in delivering health services that resonate with a significant portion of the Chinese population who seek alternatives to Western medicine. Revenue streams for Gushengtang are multifaceted. The company earns primarily through the fees charged for consultations and treatments offered at its clinics, while also generating income from the sale of TCM products. Furthermore, by cultivating partnerships with health institutions and expanding its franchise network, Gushengtang enhances its reach and scalability. The integration of technology has allowed the firm to streamline operations and offer additional services like telemedicine, adapting to the digital shift in healthcare and tapping into the broader wellness market. This diversified approach not only fortifies its market position but ensures a steady flow of revenue in a competitive industry.

Intrinsic Value
63.94 HKD
Undervaluation 54%
Intrinsic Value
Price HK$29.7
G

See Also

What is Gushengtang Holdings Ltd's Net Issuance of Debt?
Net Issuance of Debt
-14.3m CNY

Based on the financial report for Dec 31, 2025, Gushengtang Holdings Ltd's Net Issuance of Debt amounts to -14.3m CNY.

What is Gushengtang Holdings Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
45%

Over the last year, the Net Issuance of Debt growth was 0%. The average annual Net Issuance of Debt growth rates for Gushengtang Holdings Ltd have been 45% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett